Literature DB >> 25399236

Altered distribution of hippocampal interneurons in the murine Down Syndrome model Ts65Dn.

Samuel Hernández-González1, Raúl Ballestín, Rosa López-Hidalgo, Javier Gilabert-Juan, José Miguel Blasco-Ibáñez, Carlos Crespo, Juan Nácher, Emilio Varea.   

Abstract

Down Syndrome, with an incidence of one in 800 live births, is the most common genetic alteration producing intellectual disability. We have used the Ts65Dn model, that mimics some of the alterations observed in Down Syndrome. This genetic alteration induces an imbalance between excitation and inhibition that has been suggested as responsible for the cognitive impairment present in this syndrome. The hippocampus has a crucial role in memory processing and is an important area to analyze this imbalance. In this report we have analysed, in the hippocampus of Ts65Dn mice, the expression of synaptic markers: synaptophysin, vesicular glutamate transporter-1 and isoform 67 of the glutamic acid decarboxylase; and of different subtypes of inhibitory neurons (Calbindin D-28k, parvalbumin, calretinin, NPY, CCK, VIP and somatostatin). We have observed alterations in the inhibitory neuropil in the hippocampus of Ts65Dn mice. There was an excess of inhibitory puncta and a reduction of the excitatory ones. In agreement with this observation, we have observed an increase in the number of inhibitory neurons in CA1 and CA3, mainly interneurons expressing calbindin, calretinin, NPY and VIP, whereas parvalbumin cell numbers were not affected. These alterations in the number of interneurons, but especially the alterations in the proportion of the different types, may influence the normal function of inhibitory circuits and underlie the cognitive deficits observed in DS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25399236     DOI: 10.1007/s11064-014-1479-8

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  75 in total

1.  Distribution, ultrastructure, and connectivity of calretinin-immunoreactive mossy cells of the mouse dentate gyrus.

Authors:  J M Blasco-Ibáñez; T F Freund
Journal:  Hippocampus       Date:  1997       Impact factor: 3.899

Review 2.  Refining the roles of GABAergic signaling during neural circuit formation.

Authors:  Colin J Akerman; Hollis T Cline
Journal:  Trends Neurosci       Date:  2007-06-27       Impact factor: 13.837

3.  Amino acid neurotransmitter deficits in adult Down's syndrome brain tissue.

Authors:  G P Reynolds; C E Warner
Journal:  Neurosci Lett       Date:  1988-11-22       Impact factor: 3.046

4.  Memantine normalizes several phenotypic features in the Ts65Dn mouse model of Down syndrome.

Authors:  Noemí Rueda; María Llorens-Martín; Jesús Flórez; Elsa Valdizán; Pradeep Banerjee; Jose Luis Trejo; Carmen Martínez-Cué
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

5.  Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins.

Authors:  S L Eastwood; P J Harrison
Journal:  Brain Res Bull       Date:  2001-07-15       Impact factor: 4.077

6.  Differences between GABA levels in Alzheimer's disease and Down syndrome with Alzheimer-like neuropathology.

Authors:  R Seidl; N Cairns; N Singewald; S T Kaehler; G Lubec
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-02       Impact factor: 3.000

7.  Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome.

Authors:  D M Holtzman; D Santucci; J Kilbridge; J Chua-Couzens; D J Fontana; S E Daniels; R M Johnson; K Chen; Y Sun; E Carlson; E Alleva; C J Epstein; W C Mobley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

Review 8.  Epilepsy in Down syndrome: clinical aspects and possible mechanisms.

Authors:  C E Stafstrom
Journal:  Am J Ment Retard       Date:  1993

9.  Epilepsy in Down syndrome--prevalence in three age groups.

Authors:  P Johannsen; J E Christensen; H Goldstein; V K Nielsen; J Mai
Journal:  Seizure       Date:  1996-06       Impact factor: 3.184

Review 10.  Mouse models of Down syndrome as a tool to unravel the causes of mental disabilities.

Authors:  Noemí Rueda; Jesús Flórez; Carmen Martínez-Cué
Journal:  Neural Plast       Date:  2012-05-22       Impact factor: 3.599

View more
  15 in total

1.  OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome.

Authors:  Ranjie Xu; Andrew T Brawner; Shenglan Li; Jing-Jing Liu; Hyosung Kim; Haipeng Xue; Zhiping P Pang; Woo-Yang Kim; Ronald P Hart; Ying Liu; Peng Jiang
Journal:  Cell Stem Cell       Date:  2019-05-23       Impact factor: 24.633

2.  Hyper-Rigid Phasic Organization of Hippocampal Activity But Normal Spatial Properties of CA1 Place Cells in the Ts65Dn Mouse Model of Down Syndrome.

Authors:  Robert G K Munn; Aimée Freeburn; David P Finn; H Craig Heller
Journal:  J Neurosci       Date:  2022-01-03       Impact factor: 6.709

Review 3.  The GABAergic Hypothesis for Cognitive Disabilities in Down Syndrome.

Authors:  Andrea Contestabile; Salvatore Magara; Laura Cancedda
Journal:  Front Cell Neurosci       Date:  2017-03-07       Impact factor: 5.505

4.  Semilunar Granule Cells Are the Primary Source of the Perisomatic Excitatory Innervation onto Parvalbumin-Expressing Interneurons in the Dentate Gyrus.

Authors:  Laura Rovira-Esteban; Norbert Hájos; Gergő Attila Nagy; Carlos Crespo; Juan Nacher; Emilio Varea; José Miguel Blasco-Ibáñez
Journal:  eNeuro       Date:  2020-07-07

5.  Prenatal treatment with EGCG enriched green tea extract rescues GAD67 related developmental and cognitive defects in Down syndrome mouse models.

Authors:  Benoit Souchet; Arnaud Duchon; Yuchen Gu; Julien Dairou; Claire Chevalier; Fabrice Daubigney; Valérie Nalesso; Nicole Créau; Yuejin Yu; Nathalie Janel; Yann Herault; Jean Maurice Delabar
Journal:  Sci Rep       Date:  2019-03-08       Impact factor: 4.379

6.  Multi-influential genetic interactions alter behaviour and cognition through six main biological cascades in Down syndrome mouse models.

Authors:  Arnaud Duchon; Maria Del Mar Muniz Moreno; Sandra Martin Lorenzo; Marcia Priscilla Silva de Souza; Claire Chevalier; Valérie Nalesso; Hamid Meziane; Paulo Loureiro de Sousa; Vincent Noblet; Jean-Paul Armspach; Veronique Brault; Yann Herault
Journal:  Hum Mol Genet       Date:  2021-05-28       Impact factor: 6.150

Review 7.  Dissecting Alzheimer disease in Down syndrome using mouse models.

Authors:  Xun Yu Choong; Justin L Tosh; Laura J Pulford; Elizabeth M C Fisher
Journal:  Front Behav Neurosci       Date:  2015-10-13       Impact factor: 3.558

8.  Disruption of ArhGAP15 results in hyperactive Rac1, affects the architecture and function of hippocampal inhibitory neurons and causes cognitive deficits.

Authors:  Valentina Zamboni; Maria Armentano; Gabriella Sarò; Elisa Ciraolo; Alessandra Ghigo; Giulia Germena; Alessandro Umbach; Pamela Valnegri; Maria Passafaro; Valentina Carabelli; Daniela Gavello; Veronica Bianchi; Patrizia D'Adamo; Ivan de Curtis; Nadia El-Assawi; Alessandro Mauro; Lorenzo Priano; Nicola Ferri; Emilio Hirsch; Giorgio R Merlo
Journal:  Sci Rep       Date:  2016-10-07       Impact factor: 4.379

9.  Hypocellularity in the Murine Model for Down Syndrome Ts65Dn Is Not Affected by Adult Neurogenesis.

Authors:  Rosa López-Hidalgo; Raul Ballestín; Jessica Vega; José M Blasco-Ibáñez; Carlos Crespo; Javier Gilabert-Juan; Juan Nácher; Emilio Varea
Journal:  Front Neurosci       Date:  2016-03-02       Impact factor: 4.677

10.  Alterations of in vivo CA1 network activity in Dp(16)1Yey Down syndrome model mice.

Authors:  Matthieu Raveau; Denis Polygalov; Roman Boehringer; Kenji Amano; Kazuhiro Yamakawa; Thomas J McHugh
Journal:  Elife       Date:  2018-02-27       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.